Recurrence rates and relapse-free survival for patients with completely resected melanoma: Contemporary experience.
2020
e22080Background: An estimated 100,000 new diagnoses of malignant melanoma are expected in 2020. Systemic treatment with immune checkpoint inhibitors (ICIs) and targeted therapy with BRAF/MEK inhib...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI